Leef BrandsLEEEF -3.00%30 EBITDA Margin % is 15.28% as of Mar. 2026. GuruFocus rates LEEEF with a GF Score™ of 30/100 and a GF Value™ of $0.13 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 955 Drug Manufacturers companies, Leef Brands ranks worse than 86.81% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Leef Brands's EBITDA for the
three
months ended in Mar. 2026 was $1.43 Mil. Leef Brands's Revenue for the
three
months ended in Mar. 2026 was $9.38 Mil. Therefore, Leef Brands's EBITDA margin for the quarter that ended in Mar. 2026 was 15.28%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Leef Brands EBITDA Margin % Related Terms
Leef Brands EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Leef Brands's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Leef Brands's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leef Brands (LEEEF) has a EBITDA Margin % of 15.28% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Leef Brands and its competitors. According to the industry distribution chart, Leef Brands ranks #829 out of 955 companies in the Drug Manufacturers industry, placing it in the top 86.8%.
Is Leef Brands' EBITDA Margin % too high?
Leef Brands' current EBITDA Margin % is 15.28%. The Drug Manufacturers industry median EBITDA Margin % is 12.39. Leef Brands' value of 15.28% is 23.3% above this industry median. Based on the distribution chart, Leef Brands ranks #829 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Leef Brands has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' EBITDA Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #829 out of 955 companies for EBITDA Margin %. This places Leef Brands in the lower half of its industry. The industry median EBITDA Margin % is 12.39. Leef Brands' value of 15.28% is 23.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leef Brands's current EBITDA Margin % of 15.28% is 23.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Leef Brands and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current EBITDA Margin % is 15.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.13, compared to a current price of $0.17 — trading 33.3% above its estimated fair value. The current EBITDA Margin % is 15.28% and 23.3% above the Drug Manufacturers industry median of 12.39. Leef Brands' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Leef Brands (LEEEF), the current EBITDA Margin % is 15.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.17 is trading 33.3% above its estimated GF Value™ of $0.13.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
EBITDA Margin %: 15.28%
GF Value™: $0.13 vs. price of $0.17 (33.3% above fair value)
Industry Position: 23.3% above the Drug Manufacturers median (#829 of 955)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
30GF Score
Get the complete analysis for LEEEF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
